1,067 results on '"Presta, Marco"'
Search Results
2. Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryos
3. Discovery of novel FGF trap small molecules endowed with anti-myeloma activity
4. The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer
5. Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer
6. FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer
7. Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase
8. The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination
9. Fibroblast Growth Factors
10. Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity
11. β-Galactosylceramidase in cancer: friend or foe?
12. Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma
13. Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells
14. Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence
15. Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88
16. Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas
17. A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis
18. Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes
19. Proteomic Analysis Highlights the Impact of the Sphingolipid Metabolizing Enzyme β-Galactosylceramidase on Mitochondrial Plasticity in Human Melanoma
20. d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3
21. Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications
22. Zebrafish disease models in hematology: Highlights on biological and translational impact
23. Dataset: Impact of β-galactosylceramidase Overexpression on the Protein Profile of Braf(V600E) Mutated Melanoma Cells
24. Fibroblast Growth Factors
25. Quantification of Tumor Vasculature by Analysis of Amount and Spatial Dispersion of Caliber-Classified Vessels
26. Dendritic cells in inflammatory angiogenesis and lymphangiogenesis
27. Long pentraxin 3: A novel multifaceted player in cancer
28. Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
29. Cell Membrane GM 1 Ganglioside is a Functional Coreceptor for Fibroblast Growth Factor 2
30. Vascular and Stromal Contributions to Tumor Bone-Homing: Focus on Multiple Myeloma
31. List of contributors
32. Zebrafish embryo as an experimental model to study tumor angiogenesis
33. N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors
34. The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells
35. Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases
36. COSMOS-rice technology abrogates the biotoxic effects of municipal solid waste incinerator residues
37. Blocking the FGF/FGFR system as a ⿿two-compartment⿿ antiangiogenic/antitumor approach in cancer therapy
38. Supplementary Figure 1 from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
39. Supplementary Figure 3 from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
40. Data from Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone–Regulated Tumors
41. Supplementary Figure Legends 1-3 from The Thymidine Phosphorylase Inhibitor 5′-O-Tritylinosine (KIN59) Is an Antiangiogenic Multitarget Fibroblast Growth Factor-2 Antagonist
42. Supplementary Figure Legend from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
43. Supplementary Figure 4 from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
44. Supplementary Table 1 from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
45. Supplementary Figure 1 from The Thymidine Phosphorylase Inhibitor 5′-O-Tritylinosine (KIN59) Is an Antiangiogenic Multitarget Fibroblast Growth Factor-2 Antagonist
46. Data from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
47. Supplementary Figure 3 from The Thymidine Phosphorylase Inhibitor 5′-O-Tritylinosine (KIN59) Is an Antiangiogenic Multitarget Fibroblast Growth Factor-2 Antagonist
48. Supplementary Figures 1-5 from Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone–Regulated Tumors
49. Supplementary Figure 2 from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
50. Data from The Thymidine Phosphorylase Inhibitor 5′-O-Tritylinosine (KIN59) Is an Antiangiogenic Multitarget Fibroblast Growth Factor-2 Antagonist
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.